These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 30769284)

  • 1. Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis.
    Khoo NKH; Fazzari M; Chartoumpekis DV; Li L; Guimaraes DA; Arteel GE; Shiva S; Freeman BA
    Redox Biol; 2019 Apr; 22():101132. PubMed ID: 30769284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity.
    Kelley EE; Baust J; Bonacci G; Golin-Bisello F; Devlin JE; St Croix CM; Watkins SC; Gor S; Cantu-Medellin N; Weidert ER; Frisbee JC; Gladwin MT; Champion HC; Freeman BA; Khoo NK
    Cardiovasc Res; 2014 Mar; 101(3):352-63. PubMed ID: 24385344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD.
    Patton A; Church T; Wilson C; Thuma J; Goetz DJ; Berryman DE; List EO; Schwartz F; McCall KD
    J Endocrinol; 2018 Jun; 237(3):337-351. PubMed ID: 29666152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
    Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
    J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 72 regulates hepatic lipid accumulation.
    Archer AE; Rogers RS; Von Schulze AT; Wheatley JL; Morris EM; McCoin CS; Thyfault JP; Geiger PC
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R696-R707. PubMed ID: 29924632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
    Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
    PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease.
    Sahin C; Melanson JR; Le Billan F; Magomedova L; Ferreira TAM; Oliveira AS; Pollock-Tahari E; Saikali MF; Cash SB; Woo M; Romeiro LAS; Cummins CL
    Mol Metab; 2024 Jul; 85():101958. PubMed ID: 38763495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer.
    Hou C; Wang Y; Zhu E; Yan C; Zhao L; Wang X; Qiu Y; Shen H; Sun X; Feng Z; Liu J; Long J
    Biochem Pharmacol; 2016 Mar; 103():85-97. PubMed ID: 26774456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte-specific Nrf2 deletion negates nitro-oleic acid benefits on glucose tolerance in diet-induced obesity.
    Chartoumpekis DV; Chen I; Salvatore SR; Schopfer FJ; Freeman BA; Khoo NKH
    Nitric Oxide; 2024 Aug; 149():75-84. PubMed ID: 38879114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
    PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
    Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
    FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
    J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
    Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
    Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.